Search for Clinical Trial Results

Sponsored By

Hyperlipoproteinemia Type II - 29 Studies Found

Status Study
Terminated Study Name: Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042)
Condition:
  • Hyperlipoproteinemia Type II
  • Homozygous Familial Hypercholester
    Date: 2013-04-24
    Interventions:
    • Drug: Anacetrapib 100 mg table
Active, not recruiting Study Name: Study to Assess the Tolerability and Efficacy of Anacetrapib Co-administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)
Condition:
  • Hyperlipoproteinemia Type II
  • Heterozygous Familial Hypercholest
    Date: 2012-01-30
    Interventions:
    • Drug: Anacetrapib one 100 mg t
Completed Study Name: Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia
Condition:
  • Hypercholesterolemia
  • Hyperlipoproteinemia Type II

Date: 2014-03-27
Interventions:
  • Drug: AEM-28 Solution for inje
Completed Study Name: Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)
Condition:
  • Atherosclerosis
  • Hypercholesterolemia
  • Date: 2007-10-31
    Interventions:
    • Drug: ezetimibe (plus simvastatin)

Not yet recruiting Study Name: Study in Participants ≥12 Years of Age With Homozygous Familial Hypercholesterolemia (hoFH)
Condition: Homozygous Familial Hypercholesterolemia
Date: 2017-05-15
Interventions:
  • Drug: Alirocumab Alirocumab SC
Recruiting Study Name: A Registration Study for Familial Hypercholesterolemia in Taiwan
Condition: Familial Hypercholesterolemia
Date: 2017-05-11
Recruiting Study Name: Greek Registry - Familial Hypercholesterolaemia
Condition: Familial Hypercholesterolemia
Date: 2017-05-02
Not yet recruiting Study Name: HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia
Condition: Homozygous Familial Hypercholesterolemia
Date: 2017-04-26
Interventions: Device: HDL Therapeutics PDS-2 System Delipidation of plasma HDL to reduce coronary atheroma
Recruiting Study Name: Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
Condition: Heterozygous Familial Hypercholesterolemia
Date: 2017-01-30
Interventions:
  • Drug: MGL-3196 Oral
Recruiting Study Name: Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia
Condition: Hypercholesterolemia, Familial
Date: 2017-01-10
Next >>>